Armand De Gramont

Boulogne-billancourt, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial.

Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 03, 2024

Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study.

Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study.

Journal: Cancers

Published: August 07, 2022

Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects.

Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 15, 2019

Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data.

Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data.

Journal: Oral oncology

Published: July 22, 2017

Ribociclib for HR-Positive, Advanced Breast Cancer.

Ribociclib for HR-Positive, Advanced Breast Cancer.

Journal: The New England journal of medicine

Published: January 20, 2017

Novel TGF-β inhibitors ready for prime time in onco-immunology.

Novel TGF-β inhibitors ready for prime time in onco-immunology.

Journal: Oncoimmunology

Published: September 06, 2016

Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.

Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 23, 2016

Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?

Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?

Journal: Targeted oncology

Published: March 22, 2016

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.

Journal: Oncotarget

Published: February 22, 2016

Adjuvant therapies in advanced hepatocellular carcinoma: moving forward from the STORM.

Adjuvant therapies in advanced hepatocellular carcinoma: moving forward from the STORM.

Journal: Trials

Published: February 21, 2016

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 04, 2015

Targeting cancer cell metabolism in pancreatic adenocarcinoma.

Targeting cancer cell metabolism in pancreatic adenocarcinoma.

Journal: Oncotarget

Published: March 08, 2015

Showing 1-12 of 26

Last Updated: 09/26/2026